A multi-million-dollar manufacturing facility capable of producing needle-free vaccine patches in Queensland within the next five years has been completed by Brisbane-based biotechnology company Vaxxas. The Vaxxas Biomedical Facility,...
A new vaccine manufacturing facility could be built in Brisbane next year after the Queensland government committed to investing up to $20 million into a “bench to bedside” medical...